Indoleamine 2, 3-Dioxygenase enzyme and IL-10 to TNF-a ratios as immune response silicone granuloma: Predictors factors

Authors

  • Ago Harlim Christian University of Indonesia image/svg+xml
  • Heri Wibowo Departement of Dermato and Venereology, Medical Faculty, Universitas Kristen Indonesia, Jakarta
  • Siti Aisah

DOI:

https://doi.org/10.66344/jpad.v32i2.1791

Keywords:

Granulomas, silicone

Abstract

Background Silicones are still being commonly used in medicine, whether in filling materials or their mixture. Some may penetrate human body tissue through injections or application with advanced medical technology, particularly transdermal administration. The study was aimed to determine predictor factors to assess the immune response to silicone filler injection.

 

Methods An analytical cross-sectional study was conducted to evaluate immune response based on blood in patients with granuloma following silicone injection compared to normal patients; The materials included blood cultures with RPMI media, which were categorized into three groups, i.e. RPMI alone, with PHA and with 3% silicone groups. Evaluation on immune response was performed by analyzing indoleamine 2, 3-dioxygenase enzyme using ELISA and detecting TNF-a, IFN-g, IL-10 cytokines using the Luminex technology. The study was conducted at Eijkman Foundation Laboratory, Faculty of Medicine, the University of Indonesia, between 2012 and 2015.

 

Results Patients with granuloma had higher levels of proinflammatory cytokines in their blood, and the ratios of TNF-a/IL-10 and TNF-a/IDO in blood were significantly different between patients with granuloma and standard control.

 

Conclusion IL-10 and IDO enzyme play critical roles in immune tolerance caused by silicone injection and can be utilized as predictors to assess immune response induced by silicone injection.

 

Author Biography

  • Ago Harlim, Christian University of Indonesia
    Departement of Dermato and Venereology Christian University of Indonesia

References

1. Prasetyono TOH. A Data Survey: Cases on complications of silicone injection in Indonesia. Indonesian Association of Plastic Surgeons survey (PERAPI). 2007.

2. Peters W, Fomarsier V. Complication from injectable material used for breast augmentation. Can J Plastic Surgery. 2009;17(3):89-96.

3. Hexsel D, Morais MR. Management of complications of injectable silicone. Facial Plast Surg. 2014;30(6):623-7.

4. Takenaka M, Tanaka M, Isobe M, Yamagichi R, Kojiro M, Sirouzu K. Angiosarcoma of the breast with silicone granuloma: A case report. Kurume Med J. 2009;56:33-7.

5. Chen YC, Chen ML, Chui YM. A case mimicking angioedema: chin silicone granulomatous reaction spreading all over the face after receiving liquid silicone injection forty years previous. Chin Med J. 2011;124(11):1747-50.

6. Kumar V, Abbas AK, Fausto N, Aster JC. Acute and chronic inflammation. Dalam: Kumar V, Abbas AK, Fausto N, Aster JC, ed. Robbins and Cotran. Pathologic Basis of Disease. 8th eds. Philadelphia: Saunders Elsevier Inc; 2004.p.45-77.

7. Agustini C, Semenzato G. Biology and immunology of granuloma. Dalam: James DG, Zumla A ed. Granulomatous disorders. United Kindom: Cambridge press; 1999.p.3-16.

8. Cakmak O, Turkoz HK, Polat S, Serin GM, Hizal E, Tanyeri H. Histopathologic response to highly purified liquid silicone injected intradermally in rat’ skin. Aesth Plast Surg. 2011;35:538-44.

9. Pasternack FR, Fox LP, Engler DE. Silicone granulomas treated with etanercept. Arch Dermatol. 2005;141(1):13–5.

10. Bondurant S, Ernster V, Herdman R. Antinuclear antibodies and silicone breast implants. In: Safety of Silicone Breast Implants. Washington: The National Academy Press;1999.p.198-214.

11. Bondurant S, Ernster V, Herdman R. Immunology of silicone. In: Safety of Silicone Breast Implants. Washington: The National Academy Press; 1999.p.179-97.

12. Guillonneau C, Hill M, Hubert FX, Chiffoleau E, Herve C, Li XL et al. CD40 Ig treatment results in allograft acceptance mediated by CD8+CD45RClowT cells, IFN-α, and indoleamine 2,3-dioxygenase. Clin Invests J. 2007;117(4):1096-1106.

13. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell. 2008;133:775-87.

14. Mottet C, Golsbayan D. CD4+CD25+Foxp3+ regulatory T cells: from basic research to potential therapeutic use. Swiss Med Wkly. 2007;137:625-34.

15. MellorAL, Munn DH. IDO expression by dendritic cells: Tolerance and tryptophan catabolism. Nat Rev Immunol. 2004;4(10):762-74.

16. A Harlem, Kanoko M, Aisah S. Classification of Foreign Body Reactions to Industrial Silicone Injection. Dermatol Surg. 2018;44(9):1174-82

17. A Harlim, Rahfiludin M Z. Silicone level in skin tissue of normal female individuals. J Pak Assoc Dermatol. 2018;28(2):134-8.

18. Karlson EW, Hankinson SE, Liang MH, Sanchez-Guerrero J, Colditz GA, Rosenau BJ, et al. Association of silicone breast implants with immunologic abnormalities: a prospective study. Am J Med. 1999;106(1):11-9.

19. MellorAL, Munn DH. IDO expression by dendritic cells: Tolerance and tryptophan catabolism. Nat Rev Immunol. 2004;4(10):762-74.

20. Abbas AK, Lichtman AH, Pillai S. Immunological tolerance and autoimmunity. In: Cellular and molecular immunology. Philadelphia: Saunders Elsevier Inc; 2015.p.315-38.

21. Agustini C, Semenzato G. Biology and immunology of granuloma. In: James DG, Zumla A ed. Granulomatous disorders. United Kindom: Cambridge press; 1999.p.3-16.

22. Anderson JM, Rodriguez A, Chang DT. Foreign body reactions to biomaterials. Semin Immunol. 2008;20(2):86-100.

Downloads

Published

01.06.2022

Issue

Section

Original Articles

How to Cite

1.
Indoleamine 2, 3-Dioxygenase enzyme and IL-10 to TNF-a ratios as immune response silicone granuloma: Predictors factors. J Pak Assoc Dermatol [Internet]. 2022 Jun. 1 [cited 2026 Sep. 6];32(2):255-63. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/1791